MJN110结构式
|
常用名 | MJN110 | 英文名 | MJN110 |
---|---|---|---|---|
CAS号 | 1438416-21-7 | 分子量 | 462.32600 | |
密度 | 1.47±0.1 g/cm3 | 沸点 | 561.5±60.0 °C | |
分子式 | C22H21Cl2N3O4 | 熔点 | N/A | |
MSDS | 中文版 美版 | 闪点 | N/A | |
符号 |
GHS07 |
信号词 | Warning |
MJN110用途MJN110 是有效的,选择性单酰基甘油脂肪酶 (MAGL) 抑制剂。MJN110 减少肝巨噬细胞数量和炎性基因表达,并减慢纤维化进程。 |
英文名 | [2,5-dioxopyrrolidin-1-yl 4-(bis(4-chlorophenyl)methyl)piperazine-1-carboxylate] |
---|---|
英文别名 | 更多 |
描述 | MJN110 是有效的,选择性单酰基甘油脂肪酶 (MAGL) 抑制剂。MJN110 减少肝巨噬细胞数量和炎性基因表达,并减慢纤维化进程。 |
---|---|
相关类别 | |
体内研究 | MJN110(i.p.;0.0818mg/kg;每天两次,持续5.5天)以剂量依赖性方式逆转慢性收缩损伤(CCI)诱导的机械异常性疼痛和热痛觉过敏。各自的ED50值(95%置信限)为0.430(0.233-0.793)mg/kg[1]。动物模型:雄性C57BL/6J小鼠18至35g[1]剂量:0.0818mg/kg给药:I.p.;每日两次,持续5.5天。结果:以剂量依赖性方式逆转CCI诱导的机械异常性疼痛和热痛觉过敏。 |
参考文献 |
密度 | 1.47±0.1 g/cm3 |
---|---|
沸点 | 561.5±60.0 °C |
分子式 | C22H21Cl2N3O4 |
分子量 | 462.32600 |
精确质量 | 461.09100 |
PSA | 70.16000 |
LogP | 3.71470 |
外观性状 | 粉末 |
储存条件 | 室温,干燥,密封 |
Effect of selective inhibition of monoacylglycerol lipase (MAGL) on acute nausea, anticipatory nausea, and vomiting in rats and Suncus murinus.
Psychopharmacol. Ser. 232(3) , 583-93, (2015) To determine the role of the endocannabinoid, 2-arachodonyl glycerol (2-AG), in the regulation of nausea and vomiting.We evaluated the effectiveness of the potent selective monoacylglycerol lipase (MA... |
|
Proteome-wide reactivity profiling identifies diverse carbamate chemotypes tuned for serine hydrolase inhibition.
ACS Chem. Biol. , (2013) Serine hydrolases are one of the largest and most diverse enzyme classes in Nature. Inhibitors of serine hydrolases are used to treat many diseases, including obesity, diabetes, cognitive dementia, an... |
|
Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors.
ACS Chem. Neurosci. 4(9) , 1322-32, (2013) Monoacylglycerol lipase (MAGL) is a principal metabolic enzyme responsible for hydrolyzing the endogenous cannabinoid (endocannabinoid) 2-arachidonoylglycerol (2-AG). Selective inhibitors of MAGL offe... |
MJN110 |
2,5-dioxopyrrolidin-1-yl 4-[bis(4-chlorophenyl)methyl]piperazine-1-carboxylate |